Company / Cost of Revenue
Vericel Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$70.7M
FY2025
5-year range
$37.6M / $70.7M
FY2021-FY2025
Trend
+8.5%
vs FY2024
Sector context
#53 of 85
Health Care
What the data says
At $71M, Vericel's cost of revenue ranks #33 of 85 in the Health Care sector. Cost of Revenue has increased for 9 consecutive years, from $17M in FY2016 to $71M in FY2025.
Based on SEC 10-K filings.
$71M in FY2025 with a 5-year CAGR of +17.1%.
Increased from $62M to $71M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +20.9%
- 5-Year CAGR
- +17.1%
- 10-Year CAGR
- -
Sector benchmark
#33 of 85 in Health CareTop 38% of 85This company $70.7M Sector average $2.0B
▼
-96.4% below sector average
Key checks
Key Insights
- Vericel's cost of revenue has grown for 9 consecutive years.
- 5-year CAGR of +17.1%, indicating consistent growth.
- In FY2025, cost of revenue increased 8.5% year-over-year.
- Ranks #53 out of 85 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $70.7M | +8.5% |
| FY2024 | $65.1M | +5.1% |
| FY2023 | $61.9M | +55.0% |
| FY2022 | $40.0M | +6.3% |
| FY2021 | $37.6M | +16.8% |
| FY2020 | $32.2M | +5.9% |
| FY2019 | $30.4M | +7.2% |
| FY2018 | $28.3M | +6.9% |
| FY2017 | $26.5M | +53.1% |
| FY2016 | $17.3M | +432225.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026